During the past decade, Cardiovascular Center of Sarasota conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiovascular Center of Sarasota" #1 sponsor was "Gilead Sciences" with 4 trials, followed by "Pfizer" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Kowa Research Institute, Inc." with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Center of Sarasota" #1 collaborator was "Albany Stratton VA Medical Center" with 1 trials as a collaborator, "Cedars-Sinai Medical Center" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator and "East Carolina University" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Center of Sarasota" are "Atrial Fibrillation" (5 trials), "Hypertension" (5 trials), "Cardiovascular Disease" (2 trials), "Congestive Heart Failure" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Cardiovascular Center of Sarasota" in a lesser frequency.

Most popular intervention types in "Cardiovascular Center of Sarasota" are "Drug" (27 trials), "Behavioral" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Darusentan" (4 trials), "Apixaban" (2 trials), "Darusentan Placebo" (2 trials) and "Fenofibrate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Center of Sarasota" are 28 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cardiovascular Center of Sarasota". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Cardiovascular Center of Sarasota, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Center of Sarasota, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".